MGLD - TGTX MULN and EFOI among pre market gainers

Turning Point Therapeutics TPTX +116% Bristol Myers to acquire Turning Point Therapeutics for over $4B in cash. The Marygold Companies (MGLD) +32%. Energy Focus (EFOI) +26%. Amylyx Pharmaceuticals AMLX +23% as FDA extends review period of ALS drug which failed panel backing. Sprague Resources SRLP +20% to be taken private by Hartree Partners for $19/unit. Okta OKTA +15% on Q1 results. StoneCo STNE +12% on Q1 results. Society Pass SOPA +11% on acquisition of Singapore-based Gorilla Networks. CN Energy (CNEY) +9%. Mullen Automotive (MULN) +7%. Chegg CHGG +7% on additional $1B buyback authorization. Redbox Entertainment (RDBX) +6%. Applied Therapeutics APLT +5% on EMA orphan drug status for metabolic disorder drug AT-007. TG Therapeutics (TGTX) +6%.

For further details see:

TGTX, MULN and EFOI among pre market gainers